Harrow

Harrow Working Capital

The Working Capital of Harrow (HROW) as of Nov 3, 2026 is 56.08 M USD. In the previous year, Working Capital was 45.82 M USD — a change of 22.40% (higher).

Working Capital

56.08 MUSD

YoY

22.40%

Last updated:

Working Capital of Harrow is 2025 56.08 M USD. Working Capital of Harrow was 2024 45.82 M USD. It decreases by 22.40% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Working Capital of Harrow is 56.08 M USD in 2025.

Working Capital of Harrow changed from 45.82 M USD to 56.08 M USD, representing a 22.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Harrow since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Harrow historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Harrow

All Key Metrics — Harrow